Evaxion Biotech A/S - ADR Stock
Evaxion Biotech A/S - ADR Stock price
Key metrics
| Market capitalization | $7.79m |
| Enterprise Value | $10.29m |
| P/E (TTM) P/E ratio | negative |
| EV/Sales (TTM) EV/Sales | 36.75 |
| P/S ratio (TTM) P/S ratio | 27.82 |
| P/B ratio (TTM) P/B ratio | 6.22 |
| Revenue (TTM) Revenue | $280.00k |
| EBIT (operating result TTM) EBIT | $-19.09m |
| Cash position | $4.58m |
Is Evaxion Biotech A/S - ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
Evaxion Biotech A/S - ADR Stock Analysis
Analyst Opinions
3 Analysts have issued a Evaxion Biotech A/S - ADR forecast:
Analyst Opinions
3 Analysts have issued a Evaxion Biotech A/S - ADR forecast:
Financial data from Evaxion Biotech A/S - ADR
| Jun '24 |
+/-
%
|
||
| Revenue | 0.28 0.28 |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | -19 -19 |
23%
23%
|
| Net Profit | -15 -15 |
38%
38%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Evaxion Biotech A/S - ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Evaxion Biotech A/S - ADR Stock News
Company Profile
Evaxion Biotech A/S discovers and develops novel immunotherapies for cancer and infectious diseases. The company was founded by Niels Iversen Møller and Andreas Holm Mattsson on 11 August, 2008 and is headquartered in Copenhagen, Denmark.
| Head office | Denmark |
| CEO | Christian Kanstrup |
| Employees | 49 |
| Founded | 2008 |
| Website | www.evaxion-biotech.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
